Currently out of the existing stock ratings of David Hoang, 65 are a BUY (77.38%), 14 are a HOLD (16.67%), 5 are a SELL (5.95%).

David Hoang

Work Performance Price Targets & Ratings Chart

Analyst David Hoang, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 55.79% that have a potential upside of 34.25% achieved within 231 days.

David Hoang’s has documented 159 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AXSM, Axsome Therapeutics at 29-Sep-2026.

Wall Street Analyst David Hoang

Analyst best performing recommendations are on APGE (APOGEE THERAPEUTICS).
The best stock recommendation documented was for APGE (APOGEE THERAPEUTICS) at 6/3/2026. The price target of $116 was fulfilled within 19 days with a profit of $31.81 (37.78%) receiving and performance score of 19.89.

Average potential price target upside

ORTX Orchard Therapeutics PLC ALLK Allakos GOSS Gossamer Bio MLNT Melinta Therapeutics PRVB Provention Bio SRPT Sarepta Therapeutics NBIX Neurocrine Biosciences ACAD ACADIA Pharmaceuticals LBPH Longboard Pharmaceuticals AXSM Axsome Therapeutics DNLI Denali Therapeutics HRMY Harmony Biosciences Holdings XENE Xenon Pharmaceuticals ALKS Alkermes Plc JAZZ Jazz Pharmaceuticals PLC PRAX Praxis Precision Medicines SAGE Sage Therapeutic SYRE Spyre Therapeutics APGE Apogee Therapeutics ATAI ATAI Life Sciences BV

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Mar-2021

$16

$-0.7 (-4.19%)

$22

3 years 25 days ago
(05-Oct-2023)

1/4 (25%)

$0.05 (0.31%)

1

Buy Since 14-Sep-2020

$34

$17.3 (103.59%)

$34

3 years 2 months 21 days ago
(09-Aug-2023)

0/4 (0%)

$28.94 (571.94%)

Buy Since 29-Dec-2021

$15

$-1.7 (-10.18%)

$15

3 years 4 months 2 days ago
(27-Jun-2023)

3/3 (100%)

$9.77 (186.81%)

107

Buy Since 18-Jul-2022

$37

$20.3 (121.56%)

$50

3 years 7 months 17 days ago
(13-Mar-2023)

0/2 (0%)

$32.05 (647.47%)

Buy Since 05-Sep-2019

$13

4 years 5 months 16 days ago
(13-May-2022)

2/2 (100%)

$-34.2 (-72.46%)

621

Show more analysts

Please expand the browser size to see the chart

Which stock is David Hoang most bullish on?

Potential upside of $124.8 has been obtained for AXSM (AXSOME THERAPEUTICS)

Which stock is David Hoang most reserved on?

Potential downside of -$0.13 has been obtained for HRMY (HARMONY BIOSCIENCES HOLDINGS)

What Year was the first public recommendation made by David Hoang?

On 2018
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?